Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma

Cited by papers we hold 4

• Cold and hot tumors: from molecular mechanisms to targeted therapy · 2024
  No notice
• Targeting the tumor stroma for cancer therapy · 2022
  No notice
• Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) · 2021
  No notice
• The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.